In this study, we used four osteosarcoma cell lines and 54 osteosarcoma patients who were diagnosed at different MSTS stages and confirmed the specificity of CUL4B overexpression and its association with osteosarcoma tumorigenesis (Figs S1 and S2). The gene discussed is CUL4B; the disease is osteosarcoma.